嘉必優(688089.SH):帝斯曼ARA專利目前已經取得核心大客户的全球供應商資格,正在進行產品驗證
格隆匯9月6日丨嘉必優(688089.SH)在接受調研時表示,國際大客户的開發流程通常需要3-5年的時間,基本需要經歷全球供應商資格認證-產品驗證-商務談判幾個基本環節,公司為迎接今年帝斯曼ARA專利到期機遇,在前些年就已經持續開展國際大客户的開發工作,目前已經取得核心大客户的全球供應商資格,正在進行產品驗證。除此之外,開發國際客户還需取得客户所在地的相關法律法規准入和相關市場的產品質量體系認證。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.